Benzo[<i>d</i>]isoxazole Derivatives as Hypoxia-Inducible Factor (HIF)-1α Inhibitors-Reference-Cited by-同舟云学术

Benzo[d]isoxazole Derivatives as Hypoxia-Inducible Factor (HIF)-1α Inhibitors

Published:2022-09-13 Issue:12 Volume:13 Page:1864-1869
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Xue Zian¹,Li Huiti¹,Xie Wenhao¹,Xu Ying²,Zhou Lu¹^ORCID,Qu Zhi-bei¹^ORCID

Affiliation:

1. Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 200120, China

2. Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Faculty of Basic Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Funder

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.2c00308

Reference45 articles.

1. World Health Organization. Global Health Observatory. 2018. Available from: https://www.who.int/data/gho.

2. Cancer Incidence and Trends

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

4. Radiotherapy for Cancer: Present and Future

5. FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy. 2021. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-drug-reduce-bone-marrow-suppression-caused-chemotherapy.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and evaluation of antitumor activity in Pseudolaric acid B Azole derivatives: Novel and potent angiogenesis inhibitor via regulation of the PI3K/AKT and MAPK mediated HIF-1/VEGF signaling pathway;European Journal of Medicinal Chemistry;2024-11

2. Strain‐Driven [3+2] Cycloaddition of Triazine 1‐Oxides with Arynes/Cyclooctyne: Access to Benzisoxazoles/Cyclooctene‐Fused Isoxazoles;European Journal of Organic Chemistry;2024-07-12

3. A patent review on hypoxia-inducible factor (HIF) modulators (2021–2023);Expert Opinion on Therapeutic Patents;2024-06-19